Aditi Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aditi Gupta has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Eric W. Klee
Center for Individualized Medicine Mayo Clinic Rochester Minnesota USA
2 shared publications Prashanth Adiga
2 shared publicationsShubhashree Uppangala
2 shared publicationsVijay Shree Dhyani
2 shared publicationsAarno Palotie
Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
1 shared publicationAlban Ziegler
Département de Biochimie et Génétique, CHU Angers et Mitolab INSERM 1083-CNRS 6015, Angers, France
1 shared publication
Latest Publications
- Open Access
- 7 November 2025
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 91 (3) , 362-379
Monogenic Contributions to Familial Endometriosis: A Scoping Review
Introduction: Endometriosis is a chronic gynecological disorder characterized by the ectopic growth of endometrial-like tissue, with emerging evidence highlighting a significant genetic contribution to its etiology. While genome-wide association studies have identified multiple common variants associated with sporadic endometriosis, the contribution of rare variants in familial endometriosis remains understudied. This scoping review aims to collate the published literature on familial endometriosis and systematically curate the genetic findings reported for familial endometriosis, including details of genetic variants, gene functions, and their associated biological pathways, to explore the monogenic inheritance of this disorder. Methods: This scoping review adhered to the PRISMA guidelines for Scoping Reviews and was registered on the Open Science Framework (OSF). A comprehensive search was conducted across four major literature databases: PubMed, Web of Science, Scopus, and Embase. The Population, Concept, Context (PCC) framework of Joanna Briggs Institute (JBI) guidance was utilized for eligibility, where the population included participants with a familial history of endometriosis. The concept comprised studies focusing on the identification of genes and genetic variants for familial endometriosis. Context included English language and peer-reviewed primary research articles involving research on the genetics of familial endometriosis from all over the world. Data were extracted on the study design, phenotypic and genotypic characteristics of patients, family history, identified genes/variants, their location, detection methods, and other details. Further investigation into the biological relevance of the identified genes in terms of their functions and pathways was done using various bioinformatic tools, including Gene Ontology, Pathway Enrichment, and Gene-Pathway Network. Results: Eight studies comprising 16 families with familial endometriosis met the inclusion criteria, which identified variants within 18 genes, including CYP1A1, GSTM1, GSTT1, CDKN2BAS, FN1, WNT4, UGT2B28, USP17L2, TNFRSF1B, CIITA, NPSR1, CRABP1, GEN1, ADGRG7, TFG, FGFR4, NALCN, and NAV2. The identified variants spanned coding as well as non-coding regions. The identified genes were implicated in key biological roles in endometriosis-relevant pathways such as estrogen metabolism, inflammation, immune regulation, epithelial-to-mesenchymal transition, and neurogenic signaling. Conclusions: This scoping review collated 18 genes implicated in familial endometriosis from across the literature, suggesting monogenic causes with rare, potentially deleterious genetic variants underlying the origin of the disease in families. Further research and functional validation on these potential candidate genes is necessary to understand the genetics of familial endometriosis, which could potentially pave the way for personalized risk prediction and targeted therapeutic strategies.
- 7 November 2025
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 91 (3) , 362-379
Open AccessMonogenic Contributions to Familial Endometriosis: A Scoping Review
Introduction: Endometriosis is a chronic gynecological disorder characterized by the ectopic growth of endometrial-like tissue, with emerging evidence highlighting a significant genetic contribution to its etiology. While genome-wide association studies have identified multiple common variants associated with sporadic endometriosis, the contribution of rare variants in familial endometriosis remains understudied. This scoping review aims to collate the published literature on familial endometriosis and systematically curate the genetic findings reported for familial endometriosis, including details of genetic variants, gene functions, and their associated biological pathways, to explore the monogenic inheritance of this disorder. Methods: This scoping review adhered to the PRISMA guidelines for Scoping Reviews and was registered on the Open Science Framework (OSF). A comprehensive search was conducted across four major literature databases: PubMed, Web of Science, Scopus, and Embase. The Population, Concept, Context (PCC) framework of Joanna Briggs Institute (JBI) guidance was utilized for eligibility, where the population included participants with a familial history of endometriosis. The concept comprised studies focusing on the identification of genes and genetic variants for familial endometriosis. Context included English language and peer-reviewed primary research articles involving research on the genetics of familial endometriosis from all over the world. Data were extracted on the study design, phenotypic and genotypic characteristics of patients, family history, identified genes/variants, their location, detection methods, and other details. Further investigation into the biological relevance of the identified genes in terms of their functions and pathways was done using various bioinformatic tools, including Gene Ontology, Pathway Enrichment, and Gene-Pathway Network. Results: Eight studies comprising 16 families with familial endometriosis met the inclusion criteria, which identified variants within 18 genes, including CYP1A1, GSTM1, GSTT1, CDKN2BAS, FN1, WNT4, UGT2B28, USP17L2, TNFRSF1B, CIITA, NPSR1, CRABP1, GEN1, ADGRG7, TFG, FGFR4, NALCN, and NAV2. The identified variants spanned coding as well as non-coding regions. The identified genes were implicated in key biological roles in endometriosis-relevant pathways such as estrogen metabolism, inflammation, immune regulation, epithelial-to-mesenchymal transition, and neurogenic signaling. Conclusions: This scoping review collated 18 genes implicated in familial endometriosis from across the literature, suggesting monogenic causes with rare, potentially deleterious genetic variants underlying the origin of the disease in families. Further research and functional validation on these potential candidate genes is necessary to understand the genetics of familial endometriosis, which could potentially pave the way for personalized risk prediction and targeted therapeutic strategies.
- Open Access
- 31 March 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (5) , 1547-1565
Congenital anomalies observed in children conceived through assisted reproductive technology—a systematic review and meta-analysis
Congenital anomalies (CAs) are a leading cause of perinatal and child mortality. With the increasing use of assisted reproductive technology (ART), there is a growing need for research on the health outcomes of children conceived through ART. This systematic review was performed to assess the incidence of CAs in ART-conceived children compared to those conceived naturally. This review followed the PRISMA 2020 guidelines and was registered with PROSPERO. A total of 113 studies were included in this meta-analysis, comprising 768,929 children in the ART group and 40,709,337 children in the control group which comprised spontaneously conceived (SC) children. The primary findings indicated that ART-conceived children have a marginally higher risk of CAs compared to the control group. Subgroup analyses showed that children conceived via ICSI, Day 3 transfer, and fresh embryo transfer (ET) had a slightly higher risk of CAs than those conceived via IVF, Day 5 transfer, or frozen embryo transfer (FET). The study highlights a slightly increased incidence of CAs among ART-conceived children over SC children, underscoring the importance of improving ART methods and closely monitoring the health of these children to reduce the risk of CAs.
- 31 March 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (5) , 1547-1565
Open AccessCongenital anomalies observed in children conceived through assisted reproductive technology—a systematic review and meta-analysis
Congenital anomalies (CAs) are a leading cause of perinatal and child mortality. With the increasing use of assisted reproductive technology (ART), there is a growing need for research on the health outcomes of children conceived through ART. This systematic review was performed to assess the incidence of CAs in ART-conceived children compared to those conceived naturally. This review followed the PRISMA 2020 guidelines and was registered with PROSPERO. A total of 113 studies were included in this meta-analysis, comprising 768,929 children in the ART group and 40,709,337 children in the control group which comprised spontaneously conceived (SC) children. The primary findings indicated that ART-conceived children have a marginally higher risk of CAs compared to the control group. Subgroup analyses showed that children conceived via ICSI, Day 3 transfer, and fresh embryo transfer (ET) had a slightly higher risk of CAs than those conceived via IVF, Day 5 transfer, or frozen embryo transfer (FET). The study highlights a slightly increased incidence of CAs among ART-conceived children over SC children, underscoring the importance of improving ART methods and closely monitoring the health of these children to reduce the risk of CAs.
- 10 February 2023
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (5) , 1116-1128
Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia
PURPOSE: Germline missense variants of unknown significance in cancer-related genes are increasingly being identified with the expanding use of next-generation sequencing. The ataxia telangiectasia–mutated ( ATM) gene on chromosome 11 has more than 1,000 germline missense variants of unknown significance and is a tumor suppressor. We aimed to determine if rare germline ATM variants are more frequent in chronic lymphocytic leukemia (CLL) compared with other hematologic malignancies and if they influence the clinical characteristics of CLL. METHODS: We identified 3,128 patients (including 825 patients with CLL) in our hematologic malignancy clinic who had received clinical-grade sequencing of the entire coding region of ATM. We ascertained the comparative frequencies of germline ATM variants in categories of hematologic neoplasms, and, in patients with CLL, we determined whether these variants affected CLL-associated characteristics such as somatic 11q deletion. RESULTS: Rare germline ATM variants are present in 24% of patients with CLL, significantly greater than that in patients with other lymphoid malignancies (16% prevalence), myeloid disease (15%), or no hematologic neoplasm (14%). Patients with CLL with germline ATM variants are younger at diagnosis and twice as likely to have 11q deletion. The ATM variant p.L2307F is present in 3% of patients with CLL, is associated with a three-fold increase in rates of somatic 11q deletion, and is a hypomorph in cell-based assays. CONCLUSION: Germline ATM variants cluster within CLL and affect the phenotype of CLL that develops, implying that some of these variants (such as ATM p.L2307F) have functional significance and should not be ignored. Further studies are needed to determine whether these variants affect the response to therapy or account for some of the inherited risk of CLL.
- 10 February 2023
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (5) , 1116-1128
Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia
PURPOSE: Germline missense variants of unknown significance in cancer-related genes are increasingly being identified with the expanding use of next-generation sequencing. The ataxia telangiectasia–mutated ( ATM) gene on chromosome 11 has more than 1,000 germline missense variants of unknown significance and is a tumor suppressor. We aimed to determine if rare germline ATM variants are more frequent in chronic lymphocytic leukemia (CLL) compared with other hematologic malignancies and if they influence the clinical characteristics of CLL. METHODS: We identified 3,128 patients (including 825 patients with CLL) in our hematologic malignancy clinic who had received clinical-grade sequencing of the entire coding region of ATM. We ascertained the comparative frequencies of germline ATM variants in categories of hematologic neoplasms, and, in patients with CLL, we determined whether these variants affected CLL-associated characteristics such as somatic 11q deletion. RESULTS: Rare germline ATM variants are present in 24% of patients with CLL, significantly greater than that in patients with other lymphoid malignancies (16% prevalence), myeloid disease (15%), or no hematologic neoplasm (14%). Patients with CLL with germline ATM variants are younger at diagnosis and twice as likely to have 11q deletion. The ATM variant p.L2307F is present in 3% of patients with CLL, is associated with a three-fold increase in rates of somatic 11q deletion, and is a hypomorph in cell-based assays. CONCLUSION: Germline ATM variants cluster within CLL and affect the phenotype of CLL that develops, implying that some of these variants (such as ATM p.L2307F) have functional significance and should not be ignored. Further studies are needed to determine whether these variants affect the response to therapy or account for some of the inherited risk of CLL.
- Open Access
- 5 August 2022
- Published by Elsevier in Kidney International Reports
- Vol. 7 (9) , 1930-1932
Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
- 5 August 2022
- Published by Elsevier in Kidney International Reports
- Vol. 7 (9) , 1930-1932
Open AccessHeterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
- 26 June 2019
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 179 (9) , 1764-1777
Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification
Diffuse idiopathic skeletal hyperostosis (DISH) is a disorder principally characterized by calcification and ossification of spinal ligaments and entheses. Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disabling disorder characterized by progressive ossification of skeletal muscle, fascia, tendons, and ligaments. These conditions manifest phenotypic overlap in the ossification of tendons and ligaments. We describe herein a patient with DISH, exhibiting heterotopic ossification of the posterior longitudinal ligament where clinical whole exome sequencing identified a variant within ACVR1, a gene implicated in FOP. This variant, p.K400E, is a novel variant, not identified previously, and occurs in a highly conserved region across orthologs. We used sequence‐based predicative algorithms, molecular modeling, and molecular dynamics simulations, to test the potential for p.K400E to alter the structure and dynamics of ACVR1. We applied the same modeling and simulation methods to established FOP variants, to identify the detailed effects that they have on the ACVR1 protein, as well as to act as positive controls against which the effects of p.K400E could be evaluated. Our in silico molecular analyses support p.K400E as altering the behavior of ACVR1. In addition, functional testing to measure the effect of this variant on BMP‐pSMAD 1/5/8 target genes was carried out which revealed this variant to cause increased ID1 and Msx2 expression compared with the wild‐type receptor. This analysis supports the potential for the variant of uncertain significance to contribute to the patient's phenotype.
- 26 June 2019
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 179 (9) , 1764-1777
Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification
Diffuse idiopathic skeletal hyperostosis (DISH) is a disorder principally characterized by calcification and ossification of spinal ligaments and entheses. Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disabling disorder characterized by progressive ossification of skeletal muscle, fascia, tendons, and ligaments. These conditions manifest phenotypic overlap in the ossification of tendons and ligaments. We describe herein a patient with DISH, exhibiting heterotopic ossification of the posterior longitudinal ligament where clinical whole exome sequencing identified a variant within ACVR1, a gene implicated in FOP. This variant, p.K400E, is a novel variant, not identified previously, and occurs in a highly conserved region across orthologs. We used sequence‐based predicative algorithms, molecular modeling, and molecular dynamics simulations, to test the potential for p.K400E to alter the structure and dynamics of ACVR1. We applied the same modeling and simulation methods to established FOP variants, to identify the detailed effects that they have on the ACVR1 protein, as well as to act as positive controls against which the effects of p.K400E could be evaluated. Our in silico molecular analyses support p.K400E as altering the behavior of ACVR1. In addition, functional testing to measure the effect of this variant on BMP‐pSMAD 1/5/8 target genes was carried out which revealed this variant to cause increased ID1 and Msx2 expression compared with the wild‐type receptor. This analysis supports the potential for the variant of uncertain significance to contribute to the patient's phenotype.
- Open Access
- 26 June 2019
- Published by Elsevier in Genetics in Medicine
- Vol. 21 (12) , 2723-2733
CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum
- 26 June 2019
- Published by Elsevier in Genetics in Medicine
- Vol. 21 (12) , 2723-2733
Open AccessCTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum
- Open Access
- 19 February 2019
- Published by Wiley in Clinical Case Reports
- Vol. 7 (4) , 632-637
Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants
Key Clinical Message: We report a patient with developmental delay, autism, epilepsy, macrocephaly, facial dysmorphism, gastrointestinal, and behavioral issues due to EXT2 compound heterozygous likely pathogenic variants. This case report expands the EXT2 gene mutation database and the clinical spectrum of patients with deficiencies in the heparan sulfate pathway.
- 19 February 2019
- Published by Wiley in Clinical Case Reports
- Vol. 7 (4) , 632-637
Open AccessDevelopmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants
Key Clinical Message: We report a patient with developmental delay, autism, epilepsy, macrocephaly, facial dysmorphism, gastrointestinal, and behavioral issues due to EXT2 compound heterozygous likely pathogenic variants. This case report expands the EXT2 gene mutation database and the clinical spectrum of patients with deficiencies in the heparan sulfate pathway.
- 3 August 2017
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 32 (6) , 1889-1900
Asparagine Synthetase deficiency-report of a novel mutation and review of literature
Asparagine synthetase deficiency is a rare inborn error of metabolism caused by a defect in ASNS, a gene encoding asparagine synthetase. It manifests with a severe neurological phenotype manifesting as severe developmental delay, congenital microcephaly, spasticity and refractory seizures. To date, nineteen patients from twelve unrelated families have been identified. Majority of the mutations are missense and nonsense mutations in homozygous or compound heterozygous state. We add another case from India which harbored a novel homozygous missense variation in exon 11 and compare the current case with previously reported cases.
- 3 August 2017
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 32 (6) , 1889-1900
Asparagine Synthetase deficiency-report of a novel mutation and review of literature
Asparagine synthetase deficiency is a rare inborn error of metabolism caused by a defect in ASNS, a gene encoding asparagine synthetase. It manifests with a severe neurological phenotype manifesting as severe developmental delay, congenital microcephaly, spasticity and refractory seizures. To date, nineteen patients from twelve unrelated families have been identified. Majority of the mutations are missense and nonsense mutations in homozygous or compound heterozygous state. We add another case from India which harbored a novel homozygous missense variation in exon 11 and compare the current case with previously reported cases.